Ifinatamab
Product Specifications
CAS Number
2484870-90-6
Target
Immunology/Inflammation related|||B7|||Integrin
Related Pathways
Immunology/Inflammation|||Cytoskeletal Signaling
Purity
0.991
Bioactivity
Ifinatamab is a humanised monoclonal immunoglobulin that targets and inhibits the B7-H3 protein. Ifinatamab can be used to synthesise the ADC drug Ifinatamab deruxtecan for the treatment of small cell lung cancer (SCLC) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
